Ropinirole 0.25 mg Tablets Under Fasting Conditions
NCT00829504
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
44
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Ropinirole HCl 0.25 mg Tablets
DRUG:
Requip® 0.25 mg Tablets
Sponsor
Teva Pharmaceuticals USA